Skip to main content
Equibles
EPC logo

EPC · EDGEWELL PERSONAL CARE Co · Documents

Track EPC — free

Use EPC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research EPC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$27.28 -1.46 (-5.08%) At close · Nov 13 Play latest call Q4 2026 earnings call transcript
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.26B
Shares
46.09M
Volume · Nov 13 634.09K Avg daily vol (3M) 537.22K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report New FY2026 Revenue $2B up 1.8% 10-K filed Nov 13, 2026 Quarterly report FY2026 Q3 Revenue $570.1M up 1.7% 10-Q filed Aug 5, 2026 Latest results New Financial results 8-K filed Nov 12, 2026 Earnings call New Q4 2026 earnings call Held Nov 12, 2026
2026
Nov 13
Annual report 10-K FY2026, ended Sep 30
Feminine Care sale pays down debt amid higher organic sales

Edgewell closed the sale of Feminine Care to Essity Aktiebolag (publ) on February 2, 2026, receiving approximately $340 and using proceeds to repay debt. Fiscal 2026 net sales rose 1.8% to $1,996.5, while organic sales increased 0.3%.

Revenue $2B ▲ 1.8% Net loss $51.7M Diluted EPS -$1.12
Read from the MD&A section
3 source passages
On February 2, 2026, we closed the sale of our Feminine Care business to Essity Aktiebolag (publ) (“Essity”) and received proceeds of approximately $340 on a cash-free and debt-free basis. The decrease in interest expense was the result of lower borrowing levels on the Company’s U.S. revolving credit facility due to the paydown of the facility with the proceeds of the Feminine Care divestiture. During fiscal 2026, net sales were $1,996.5, an increase of $34.5, or 1.8%, including a $28.2 favorable impact due to currency movements. Organic net sales increased $6.3, or 0.3%. Open the document at this passage
Sep 23
Current report 8-K Events of Sep 17
Director or officer change, or executive pay

Edgewell Personal Care Company determined that LaTanya Langley will serve as Chief Administrative and Legal Officer and Corporate Secretary effective October 1, 2026, when she will no longer serve as Chief People Officer. Her compensation will not change.

Aug 5
Quarterly report 10-Q FY2026 Q3, ended Jun 30
Quarterly report for FY2026 Q3 AI summary on its way
Revenue $570.1M ▲ 1.7% Net income $13.7M ▼ 52.9% Diluted EPS $0.29 ▼ 53.2%
May 6
Quarterly report 10-Q FY2026 Q2, ended Mar 31
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $519.5M ▲ 0.6% Net loss $10.6M Diluted EPS -$0.22
Feb 9
Quarterly report 10-Q FY2026 Q1, ended Dec 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $422.8M ▲ 1.9% Net loss $65.7M Diluted EPS -$1.41
2025
Nov 18
Annual report 10-K FY2025, ended Sep 30
Annual report for FY2025
Revenue $2.22B ▼ 1.3% Net income $25.4M ▼ 74.2% Diluted EPS $0.53 ▼ 73.1%
Aug 5
Quarterly report 10-Q FY2025 Q3, ended Jun 30
Quarterly report for FY2025 Q3
Revenue $627.2M ▼ 3.2% Net income $29.1M ▼ 40.6% Diluted EPS $0.62 ▼ 36.7%
May 7
Quarterly report 10-Q FY2025 Q2, ended Mar 31
Quarterly report for FY2025 Q2
Revenue $580.7M ▼ 3.1% Net income $29M ▼ 19.4% Diluted EPS $0.60 ▼ 16.7%
2024
Nov 14
Annual report 10-K FY2024, ended Sep 30
Annual report for FY2024
Revenue $2.25B ▲ 0.1% Net income $98.6M ▼ 14.0% Diluted EPS $1.97 ▼ 10.9%
Aug 6
Quarterly report 10-Q FY2024 Q3, ended Jun 30
Quarterly report for FY2024 Q3
Revenue $647.8M ▼ 0.3% Net income $49M ▼ 7.5% Diluted EPS $0.98 ▼ 3.9%
Showing 1–50 of 139 documents
Key facts CIK 1096752 CUSIP 28035Q102 13F (30d) 199 filings 177 filers Visit website Investor relations